Releaf
Scott Stephen currently serves as the Chief Financial Officer at Releaf since April 2023. Prior to this role, Scott held a position in Corporate Finance at Blackphenix from December 2018 to March 2023, and worked at PwC as a Senior Associate and Associate from August 2016 to December 2018. Educational credentials include a Master of Science in Capital Markets from Henley Business School, an ACA degree from ICAEW, and membership with The Chartered Institute for Securities & Investment. Additional education includes participation in the Financial Leaders of Tomorrow Summer Program at Tsinghua University and an Erasmus Exchange at the University of Mannheim. Scott's earlier experience includes roles at Aker Solutions as a Finance Placement and as a Business Analyst at Odfjell Drilling, along with an internship at Nor-Ocean Offshore AS.
This person is not in any teams
Releaf
1 followers
Releaf, founded in 2022, is a healthcare company dedicated to transforming patient access to Cannabis Based Products for Medical use (CBPMs) in the UK. Despite the legalisation of medical cannabis in 2019, its uptake has been limited. An estimated 1.8 million people in the UK rely on illicit street cannabis for medical purposes, while over 20 million adults could benefit from CBPMs but are unaware of their options. Currently, only around 30,000 people in the UK have an active CBPM prescription. The primary obstacles to broader adoption are the complexity of the prescribing process and a lack of awareness among medical professionals and potential patients. Releaf has made significant investments in developing a HealthTech platform to streamline access to CBPMs for patients with various health conditions. The platform was launched in February 2024, eliminating previous barriers and bringing about fundamental changes in the UK's CBPM sector. Our Leadership Team has a proven track record in navigating complex, regulated markets. Through substantial investments in time, money, and expertise, we have developed Releaf's HealthTech operating platform. This platform simplifies the intricate and makes the opaque transparent, ensuring a seamless, single online session for patients to access CBPMs for their relevant conditions. Press enquiries: Press@releaf.co.uk